To compare the diagnostic accuracy of fl uorine 18 fl uorodeoxyglucose (FDG) positron emission tomography (PET) in the detection of colon lesions with that of delayed PET/ computed tomography (CT) performed after the administration of a laxative-augmented contrast medium.
Use of Laxative-augmented Contrast Medium in the Evaluation of Colorectal Foci at FDG PET 
Purpose:
To compare the diagnostic accuracy of fl uorine 18 fl uorodeoxyglucose (FDG) positron emission tomography (PET) in the detection of colon lesions with that of delayed PET/ computed tomography (CT) performed after the administration of a laxative-augmented contrast medium.
Materials and Methods:
All patients gave written informed consent according to the guidelines issued by the institutional review board. In a prospective study performed from November 2005 to December 2006, images obtained in 847 patients were reviewed by two physicians in consensus. Colorectal FDG uptake on initial PET images that exceeded background FDG accumulation was graded as minimal, equivocal, or positive. When the initial PET scan revealed a colorectal region of increased uptake, either oral or anal laxativeaugmented contrast medium was administered on the basis of the site of colorectal FDG focus and delayed PET/CT was performed. Initial PET fi ndings were reevaluated and revised when necessary. Comparison was performed on a per-patient basis. Findings at histopathologic analysis and clinical follow-up served as the reference standard. The accuracy of PET was compared with that of PET/CT by using the McNemar test.
Results:
Colorectal FDG foci were seen on initial images in 137 patients. Uptake on the initial images was reported as minimal in 14 patients, equivocal in 68, and positive in 55. With use of a laxative-augmented contrast medium and delayed PET/CT, the proportions of equivocal and positive results decreased by 84% (57 of 68 patients) and 58% (18 of 31 patients), respectively. The accuracy of delayed PET/CT in the depiction of colorectal cancer was greater than that of initial PET (93.4% [128 of 137 patients] vs 71.5% [98 of 137 patients], respectively; P , .01).
Conclusion:
Delayed PET/CT with laxative-augmented contrast medium is more accurate than initial PET alone in the detection of colorectal cancer. This approach has promise as a tool for guiding decisions about how to treat patients with colorectal FDG foci.
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Laxative-augmented Contrast Medium
Laxative-augmented contrast medium was administered orally or per rectum. For the oral formula, 500 mL of diluted 3% contrast medium (iothalamate meglumine [Conray 60; Mallinckrodt, St Louis, Mo]) was mixed with 125 mL of magnesium citrate (MagVac; Purzer Pharmaceutical, Princeton, NJ). The rec tal protocol FDG is excreted in part by the gastrointestinal tract, with accumulation expected normally in the stomach and small and large intestines ( 8 ) . These physiologic sites of FDG accumulation may be confused with malignant lesions, and similarly increased FDG accumulation in malignant lesions may erroneously be interpreted as unrelated to cancer ( 7 ) . We hypothesized that the use of laxativeaugmented contrast medium before delayed FDG PET/CT might improve the detection of abnormal colorectal FDG foci. The purpose of this study was to compare the diagnostic accuracy of initial FDG PET in the detection of colon lesions with that of delayed PET/CT performed after the administration of laxativeaugmented contrast medium. ( 1 ) . Several studies have demonstrated that fl uorine18 fl uorodeoxyglucose (FDG) positron emission tomography (PET) is sensitive in the detection of colorectal malignancy. Its usefulness has been proved in the treatment of patients with colorectal cancer ( 2-4 ). The specifi city of FDG PET in the detection of colorectal cancer, however, is limited by its high false-positive rate ( 2, 4 ) .
Materials and Methods

Patients
Colorectal cancers are associated with increased FDG uptake; however, benign, infectious, infl ammatory, and granulomatous processes may also cause an increase in FDG uptake. A focal and well-circumscribed intraabdominal area of increased FDG uptake may be interpreted as equivocal or suggestive of malignancy without anatomic localization. Although the computed tomographic (CT) component of a hybrid PET/CT system may be helpful for locating and characterizing foci of increased FDG uptake within the bowel ( 5 ), the integrative interpretation of PET features with corresponding CT characteristics has resulted in false-positive rates of 13%-29 % ( 6,7 ).
Implications for Patient Care
The use of a laxative-augmented n contrast medium before delayed FDG PET/CT led to a reduction in the number of false-positive fi ndings and increased the accuracy in the detection of colorectal cancer, suggesting that this procedure may be helpful in the management of colorectal foci seen at initial PET.
Delayed PET/CT performed after n administration of a laxativeaugmented contrast medium might be useful for identifying patients needing additional diagnostic procedures or to avoid unnecessary colonoscopic evaluation. 
Advances in Knowledge
Reference Standard
In 65 patients, colonoscopy, which was performed for clinical indications, was used as the reference standard. Fortyone of these patients underwent biopsy. In preparation for colonoscopy, each patient was instructed to ingest 250 mL of magnesium citrate solution (MagVac; Purzer Pharmaceutical, Princeton, NJ) and 15 mg of bisacodyl (Ducolax; Boehringer Ingelheim, Ingelheim, Germany) on the evening before the examination. Three hours before the examination, all patients received a 10-mg bisacodyl suppository (Ducolax Suppositories, Boehringer Ingelheim). Flexible endoscopy procedures were performed after thorough oral lavage. Typically, the procedure was carried out by an experienced gastroenterologist. The cecum was reached in 100% of colonoscopy procedures. All lesions that appeared possibly malignant were sampled for biopsy and the site of the lesion was recorded. All tissue specimens were subjected to histologic examination.
In 72 patients who did not undergo colonoscopy, follow-up was obtained from chart review and telephone interview. The clinical follow-up period ranged four-detector row spiral CT unit (LightSpeed, GE Medical Systems). Images were acquired in fi ve to seven bed positions by using the following parameters: 140 kV, 40 mA, 0.8 second per CT rotation, a pitch of 6, a table speed of 22.5 mm/sec, coverage of 722.5-1011.5 mm, and an acquisition time of 31.9-37.0 seconds. CT was performed before emission acquisition. CT data were resized from a 512 3 512 matrix to a 128 3 128 matrix to match the PET data so that the images could be fused, and CT transmission maps were generated. The full width at half maximum for PET/CT was 4.8 mm. After intravenous administration of 370 MBq (10 mCi) of FDG, emission images were acquired for 5 minutes per bed position. The time between FDG injection and the beginning of emission scanning was approximately 50-70 minutes. Image datasets were iteratively reconstructed by using the ordered-subset expectation maximization method. Images were displayed for visual interpretation in three orthogonal projections and with whole-body maximum intensity projection (MIP). Delayed images were obtained only with the integrated PET/CT scanner (Discovery LS). Acquisition and processing of delayed PET/CT scans were performed in the same manner as the initial PET/CT scans, with the exception that the range of image acquisition was limited to the region of interest identifi ed on the initial scan. A workstation (Xeleris; Elegems, Haifa, Israel) was used for image display and analysis.
Image Interpretation
Images were interpreted in consensus by two nuclear medicine physicians (J.S.C. and Y.K.C., with 4 and 8 years of PET experience, respectively). When consensus could not be reached, the opinion of the senior nuclear medicine physician (Y.K.C.) was accepted. The readers were aware of the patients' clinical history, which was provided by the referring physician, but were unaware of any results of other imaging examinations, if these had been performed. Initially, the attenuation-corrected PET images were reviewed with MIP in the consisted of an initial phosphosoda enema (Fleet; C.B. Fleet, Lynchburg, Va). Following evacuation, 500 mL of diluted 3% contrast medium was instilled into the anus.
When the initial PET scan revealed a colorectal region of increased uptake, either oral or anal laxative-augmented contrast medium was administered on the basis of the site of the colorectal FDG focus, before delayed PET/CT scans were acquired. Because a prior study by Chou and colleagues ( 9 ) showed that the time required for orally ingested laxativeaugmented contrast medium to reach the ascending colon, transverse colon, and descending colon varied from approximately 80 to 120 minutes, delayed PET/CT scans were obtained approximately 90-120 minutes after laxativeaugmented contrast medium ingestion, when the initial region of suspicious PET uptake was noted in the ascending or transverse colon. If the suspicious lesion seen at initial PET was located in the descending colon, sigmoid colon, or rectum, the patients received laxativeaugmented contrast medium per rectum and immediately underwent delayed PET/CT.
Imaging Protocol
Initial FDG PET images were obtained with either a PET scanner (Ecat Exact HR+; Siemens, Knoxville, Tenn) or an integrated PET/CT scanner (Discovery LS; GE Medical Systems, Waukesha, Wis). Patients were required to fast for at least 8 hours before the initial PET examination, and blood glucose measurements were obtained from all pa tients before the administration of FDG. A blood glucose level of less than 8 mmol/L was considered appropriate to perform the examination . As many sequential images as necessary were obtained to include the entire head, thorax, abdomen, and pelvis in initial PET or PET/ CT examinations. For the PET scanner, transmission images were obtained for 2 minutes per bed position to correct for photon attenuation by using a germanium 68 line source. For the PET/CT scanner, the PET attenuation correction factors were calculated from the CT images. CT was performed by using a ( Figs 1, 2 ) . Of the 709 patients who did not undergo delayed PET/CT after the administration of laxative-augmented contrast medium, 38 were lost to follow-up. In addition, one of the 138 patients with increased colorectal tracer uptake was lost to follow-up. Thus, a total of 710 patients were excluded from further analysis; the fi nal study cohort consisted of 137 patients (Table E1 [online]). The uptake in the abnormal FDG focus at initial PET was considered minimal in 14 of the 137 patients, equivocal in 68, and positive in 55. In 91 patients, the uptake grade determined with delayed PET/CT after the administration of laxative-augmented contrast medium were not calculated; instead, accuracy is presented in terms of the proportion of correctly classifi ed foci on a per-patient basis. Findings from initial PET and delayed PET/CT were compared in terms of accuracy by using the McNemar test. A P value of .05 was considered indicative of a statistically signifi cant difference (MedCalc 11.0; MedCalc Software, Mariakerke, Belgium).
Results
Areas of increased tracer uptake in the colon or rectum were noted at initial PET examination in 138 of the 847 patients . These patients underwent delayed PET/ CT after administration of laxativefrom 2.5 to 3.6 years, with a mean of 3.1 years.
Data and Statistical Analyses
Abnormal colorectal foci on initial PET and delayed PET/CT images were classifi ed as showing minimal, equivocal, or positive uptake . Foci showing minimal and equivocal uptake were considered to be physiologic and benign, and fi ndings at initial PET and delayed PET/CT were classifi ed as true positive, true negative, false positive, or false negative. Because only abnormal FDG foci of the colorectum were analyzed and the patients who did not undergo colonoscopic evaluation did not have an adequately long follow-up, sensitivity and specifi city 
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Chen et al rhoids, erosion, postoperative granulation changes, adenoma, adenoma with dysplasia, and adenocarcinoma (in addition to physiologic phenomena). Of the 23 patients who initially showed a segmental pattern, four were found to have adenocarcinoma (two in the sigmoid colon and two in the rectum); the patterns in the other patients were confi rmed to be associated with physiologic phenomena. In patients who initially presented with a nodular-multifocal pattern, the pattern was related to either physiologic phenomena or benign causes (constipation, diverticulitis, and hemorrhoids), but not malignancy. Except for the physiologic phenomena, two patients thought to be equivocal, uptake was classifi ed as minimal with delayed PET/CT in 44 patients and as positive in 14 ( Fig 3 ) ; in the remaining 10 patients, uptake remained equivocal. Of 55 patients with areas of positive uptake on the initial scans, 30 patients were reclassifi ed as having minimal uptake at delayed PET/ CT and one patient was thought to have equivocal uptake. At initial PET, the patterns of colorectal FDG foci were as follows: 87 patients had a nodular-focal pattern, 23 had a segmental pattern, 12 had a nodular-multifocal pattern, and 15 had a diffuse pattern ( Table 2 ). The nodularfocal pattern was associated with hemorwas different from that determined at the initial PET examination ( Table 1 and  Table E2 [online]).
In 14 patients classifi ed with minimal uptake at initial PET, uptake was reclassifi ed as positive in two patients and reconfi rmed as minimal in 12. The two patients with persistent positive uptake included one patient with a mild hypermetabolic focus in the ascending colon (biopsy-proved tubular adenoma) and another with a mild hypermetabolic focus in the sigmoid colon (biopsy-proved adenoma with focal adenocarcinoma); these foci were initially classifi ed as showing minimal uptake. In 68 patients with areas of colonic uptake initially 
Chen et al with initially diffuse patterns were found to have an equivocal-grade lesion and positive-grade lesion at delayed PET/CT owing to adenoma and adenocarcinoma, respectively.
Comparison of initial PET and delayed PET/CT fi ndings with those from the reference standard is shown in Table 3 . With use of laxative-augmented contrast medium and delayed PET/CT, the number of patients with equivocal fi ndings decreased from 68 to 11 (an 83.8% decrease). In 27 patients with newly diagnosed colorectal cancers, 24 were consistently classifi ed as showing positive uptake at both initial PET and delayed PET/CT, as intense uptake was Note.-Data are given as numbers of patients.
* All 44 patients were classifi ed according to physiologic fi ndings. † Five patients had diabetes mellitus, two patients had constipation, two patients had hemorrhoids, and one patient had adenoma. ‡ Six patients had adenocarcinoma, two patients had adenoma, one patient had tubular adenoma with severe dysplasia, one patient had hemorrhoids, one patient had chronic granulomatous infl ammation, one patient had appendicitis 12 days after surgery, one patient had erosion, and one patient had diverticulitis. 
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ings are agonizing to the physicians interpreting the studies and patients alike.
Our study results suggest that the use of laxative-augmented contrast medium before delayed FDG PET/CT may reduce not only the number of false-positive interpretations but also the equivocal fi ndings of colorectal FDG foci on initial PET images, resulting in increased accuracy in the detection of colorectal cancer. The use of oral contrast medium is helpful in the interpretation of PET/CT images because it can help delineate intestinal structures at CT from other retro-and intraperitoneal organs, which leads to better localization of a colorectal FDG focus. Previous reports showed that PET/CT with 1800 mL of negative oral contrast medium can provide excellent intestinal delineation while avoiding overestimation of artifi cially high FDG activity caused by high-density bariumbased oral contrast media ( 11, 12 ) . In our study, a lesser amount of diluted positive contrast medium was given because dilute concentrations of positive contrast media can be used for coregistered PET/CT without introducing attenuation overcorrection artifacts in PET ( 13, 14 ) . Moreover, our study is different from these previous studies in that we applied diluted contrast medium by means of the oral or rectal route depending on the location of the abnormal FDG focus. Although oral or rectal contrast media are effective for opacifying the colonic tract to achieve optimal depiction of intestinal structures, the existence of undetermined FDG activity in the colorectum cannot be eliminated and remains confounding to readers. Therefore, these contrast medium-located FDG foci might require additional methods to reinforce the effects of the contrast medium.
Increased colorectal FDG uptake unrelated to cancer may be encountered on PET images; however, the mechanism of this prominent accumulation has not been fully investigated. These hypermetabolic areas, which have an uptake intensity exceeding the background level of FDG accumulation in the colorectum, could be the cause of the false-positive fi ndings obtained at negative fi ndings. At delayed PET/CT, there were 31 true-positive fi ndings, 97 true-negative fi ndings, and nine falsepositive fi ndings; there were no falsenegative fi ndings. The accuracy of initial PET and delayed PET/CT was 71.5% (98 of 137 patients) and 93.4% (128 of 137 patients), respectively ( P , .01).
Discussion
Many studies have noted that FDG PET can depict colorectal cancer with a high degree of sensitivity (range, 94%-100%) ( 2,10 ). However, false-positive fi ndings are common. These false-positive fi ndpersistently identifi ed. The remaining three patients with areas of equivocal uptake (two in the rectum and one in the transverse colon), however, were reclassifi ed as having positive uptake at delayed PET/CT. If we excluded 24 of the 27 known colorectal cancers from patients classifi ed with positive uptake at initial PET and 27 known colorectal cancers revealing a positive grade at delayed PET/CT, the number of patients with positive fi ndings decreased by 58.1% (from 31 to 13 patients). At initial PET, there were 24 true-positive fi ndings, 74 true-negative fi ndings, 31 false-positive fi ndings, and eight false- Table 2 Location Compared with a conventional PET or combined PET/CT imaging protocol, the use of a laxative-augmented contrast medium with delayed PET/CT improved the diagnostic accuracy and reduced the number of equivocal and false-positive fi ndings in patients with colorectal FDG foci. Laxative-augmented contrast medium is a kind of functional and anatomic fusion application, like the PET/CT fusion technique, because the laxative has a functional effect of promoting bowel motility whereas the contrast medium allows anatomic illustration to characterize the bowel structures. For these reasons, we recommend laxative-augmented contrast medium and delayed PET/CT to evaluate increased colorectal FDG uptake.
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One issue worth discussing is the additional radiation exposure from the CT portion of the delayed PET/CT examination. If delayed PET/CT with laxativeaugmented contrast medium was not carried out, 54 of 68 patients initially considered to have equivocal fi ndings and 31 of 55 patients initially considered to have positive fi ndings might have been referred for unnecessary colonoscopic evaluation. In addition, one patient with cancer who was initially considered to have minimal uptake would have been overlooked. Moreover, we adopted the low-dose CT protocol of delayed PET/CT to scan only the limited region of interest identifi ed at initial PET. We believe the benefi ts of delayed PET/CT with laxative-augmented contrast medium may outweigh the risks of additional low-dose radiation to the patient.
Our study has a number of potential limitations. We assessed only a single delayed scan obtained with laxativeaugmented contrast medium. We did not assess the potential effect of a delayed scan obtained with and without laxativeaugmented contrast medium; all delayed and dual-phase scans were obtained with laxative-augmented contrast medium or different constituents of laxatives and oral contrast media. Except for patients known to have FDG-avid diseases, it is diffi cult to predict which patients should receive laxative-augmented contrast medium before the initial imaging examination because not all patients will have a substantially abnormal FDG focus on the initial scan. Furthermore, the location of the colorectal FDG focus cannot be determined before the initial scan; hence, it is not possible to decide on the suitable laxative-augmented contrast medium protocol (oral vs per rectum). In particular, oral laxative-augmented contrast medium may be an acceptable alternative if some patients decline to receive an enema. The two protocolsinterpretation of the PET images. In the study by Kim and colleagues ( 15 ) , colonic FDG accumulation was frequently observed in patients with constipation. They also considered that focal FDG accumulation can be excreted into the bowel lumen because FDG radioactivity was measured in the stool from these patients. Miraldi and colleagues ( 16 ) further found that colonic FDG accumulation can be eliminated with an isosmotic laxative solution. According to these fi ndings, the use of a laxative to cleanse nonspecifi c colonic FDG focithe leading cause of false-positive interpretations in the detection of colorectal cancer-is reasonable. However, it must be understood that not all of the nonspecifi c colonic FDG accumulation can be completely eliminated by means of laxatives alone. If the intensity of a true neoplastic lesion is identical or similar to the surrounding FDG activity, which is a residue on postcleansing images, this isointense lesion may be easily missed. Therefore, the use of a laxative to augment the effect of the contrast medium can compensate for the shortcomings of each technique in terms of reducing the false-positive fi ndings.
A semiquantitative measurement that has come into widespread use in the differentiation of malignant from benign tumors at FDG PET is the standardized uptake value (SUV). There are substantial overlaps between benign and malignant lesions because SUV and neoplastic histologic characteristics of the colorectum have not been demonstrated consistently. In addition, it is not practical to calculate the retention index of dual-phase SUV when the initial uptake pattern is nodular-multifocal or diffuse because we cannot determine the proper site that represents the initial SUV. Furthermore, segmental and diffuse patterns have been conventionally described with infl ammatory processes and physiologic phenomena, respectively. Our results, however, revealed that malignant lesions can be concealed in segmental and diffuse patterns. Therefore, we decided not to use the SUV as a supplement to visual interpretation. Our re sults showed that laxative-augmented contrast NUCLEAR MEDICINE: Laxative-augmented Contrast Medium Chen et al
